Cargando…

Structure of GTP cyclohydrolase I from Listeria monocytogenes, a potential anti-infective drug target

A putative open reading frame encoding GTP cyclohydrolase I from Listeria monocytogenes was expressed in a recombinant Escherichia coli strain. The recombinant protein was purified and was confirmed to convert GTP to dihydroneopterin triphosphate (K (m) = 53 µM; v (max) = 180 nmol mg(−1) min(−1)). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Schüssler, Sonja, Haase, Ilka, Perbandt, Markus, Illarionov, Boris, Siemens, Alexandra, Richter, Klaus, Bacher, Adelbert, Fischer, Markus, Gräwert, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718149/
https://www.ncbi.nlm.nih.gov/pubmed/31475925
http://dx.doi.org/10.1107/S2053230X19010902
Descripción
Sumario:A putative open reading frame encoding GTP cyclohydrolase I from Listeria monocytogenes was expressed in a recombinant Escherichia coli strain. The recombinant protein was purified and was confirmed to convert GTP to dihydroneopterin triphosphate (K (m) = 53 µM; v (max) = 180 nmol mg(−1) min(−1)). The protein was crystallized from 1.3 M sodium citrate pH 7.3 and the crystal structure was solved at a resolution of 2.4 Å (R (free) = 0.226) by molecular replacement using human GTP cyclohydrolase I as a template. The protein is a D (5)-symmetric decamer with ten topologically equivalent active sites. Screening a small library of about 9000 compounds afforded several inhibitors with IC(50) values in the low-micromolar range. Several inhibitors had significant selectivity with regard to human GTP cyclohydrolase I. Hence, GTP cyclohydrolase I may be a potential target for novel drugs directed at microbial infections, including listeriosis, a rare disease with high mortality.